Patent details
EP2803349
Title:
Method for preparing an enriched IgG composition from plasma
Basic Information
- Publication number:
- EP2803349
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP141765115
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- Method for preparing an enriched IgG composition from plasma
- French Title of Invention:
- Procédé de préparation d'une composition d'IgG enrichie de plasma
- German Title of Invention:
- Verfahren zur Herstellung einer angereicherten IgG-Zusammensetzung aus Plasma
- SPC Number:
-
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 27/09/2023
- Link to UPP Register:
-
European Patent Register
- Unitary Effect Request Withdrawal Date:
-
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 02/10/2023
- Unitary Effect Rejection Decision Date:
-
- Unitary Effect Date:
- 27/09/2023
- Unitary Effect Registration Date:
- 02/10/2023
- Unitary Effect Re-establishment of rights Filing Date:
-
- Unitary Effect Re-establishment of rights EPO Decision :
-
- Unitary Effect Re-establishment of rights EPO Decision Date:
-
- Explanatory Text UE:
-
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
-
Dates
- Filing date:
- 27/05/2010
- Grant date:
- 27/09/2023
- EP Publication Date:
- 19/11/2014
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 27/09/2023
- EP B1 Publication Date:
- 27/09/2023
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 27/05/2030
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 20/09/2023
-
-
- Name:
- Takeda Pharmaceutical Company Limited
- Address:
- 1-1, Doshomachi 4-chome
Chuo-ku, Osaka-shi, Osaka, Japan (JP)
Inventor
1
- Name:
- Gundinger, Thomas
- Address:
- Austria (AT)
2
- Name:
- Koelbl, Bernhard
- Address:
- Austria (AT)
3
- Name:
- Schwarz, Hans-Peter
- Address:
- Austria (AT)
4
- Name:
- Pljevljakovic, Azra
- Address:
- Austria (AT)
5
- Name:
- Bruckschwaiger, Leopold
- Address:
- Austria (AT)
6
- Name:
- Grausenburger, Reinhard
- Address:
- Austria (AT)
7
- Name:
- Butterweck, Harald Arno
- Address:
- Austria (AT)
8
- Name:
- Svatos, Sonja
- Address:
- Austria (AT)
9
- Name:
- Teschner, Wolfgang
- Address:
- Austria (AT)
10
- Name:
- Nürnberger, Julia
- Address:
- Austria (AT)
Priority
- Priority Number:
- 2010202125
- Priority Date:
- 26/05/2010
- Priority Country:
- Australia (AU)
Classification
- IPC classification:
-
A61K 9/00;
C07K 1/30;
C07K 1/36;
A61K 35/16;
A61K 38/17;
A61P 13/12;
A61P 7/00;
A61P 27/02;
A61P 31/00;
A61P 37/00;
A61P 37/02;
A61P 37/04;
A61P 37/06;
A61K 9/08;
A61K 47/18;
C07K 16/06;
Publication
European Patent Bulletin
1
- Issue number:
- 202339
- Publication date:
- 27/09/2023
- Description:
- Grant (B1)
2
- Issue number:
- 202344
- Publication date:
- 01/11/2023
- Description:
- Application number/publication number of the divisional application (Art. 76) changed
3
- Issue number:
- 202344
- Publication date:
- 01/11/2023
- Description:
- Unitary Effect Request Receipt
4
- Issue number:
- 202344
- Publication date:
- 01/11/2023
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
-
- Annual Fee Number:
-
- Expected Payer:
-
- Last Annual Fee Payment Date:
-
- Last Annual Fee Paid Number:
-
- Payer:
-
Filing date |
Document type |
Number of pages |